Ming‐Ann Hsu

2.4k total citations
38 papers, 1.9k citations indexed

About

Ming‐Ann Hsu is a scholar working on Rheumatology, Hematology and General Health Professions. According to data from OpenAlex, Ming‐Ann Hsu has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 11 papers in Hematology and 9 papers in General Health Professions. Recurrent topics in Ming‐Ann Hsu's work include Spondyloarthritis Studies and Treatments (17 papers), Autoimmune and Inflammatory Disorders Research (11 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). Ming‐Ann Hsu is often cited by papers focused on Spondyloarthritis Studies and Treatments (17 papers), Autoimmune and Inflammatory Disorders Research (11 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). Ming‐Ann Hsu collaborates with scholars based in United States, Canada and United Kingdom. Ming‐Ann Hsu's co-authors include Jeffrey L. Cummings, Terry R. Barclay, John F. Schnelle, Stacey Wood, David Osoba, Peter C. Trask, Kathleen M. Bungay, John E. Ware, Martha Bayliss and David Sugano and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Affective Disorders and Medical Care.

In The Last Decade

Ming‐Ann Hsu

36 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming‐Ann Hsu United States	21	547	460	318	310	287	38	1.9k
Lynda Doward United States	31	326 0.6×	332 0.7×	478 1.5×	732 2.4×	162 0.6×	89	3.0k
R.P. Riemsma United Kingdom	23	309 0.6×	335 0.7×	424 1.3×	382 1.2×	180 0.6×	45	2.5k
Elizabeth Molsen United States	8	262 0.5×	346 0.8×	446 1.4×	150 0.5×	220 0.8×	8	2.6k
Emuella Flood United States	25	447 0.8×	177 0.4×	235 0.7×	162 0.5×	84 0.3×	82	2.0k
Margreet Scharloo Netherlands	28	395 0.7×	642 1.4×	105 0.3×	214 0.7×	205 0.7×	41	2.5k
Henry J. Henk United States	28	363 0.7×	255 0.6×	258 0.8×	126 0.4×	361 1.3×	84	2.5k
Paul Swinburn United Kingdom	13	157 0.3×	293 0.6×	529 1.7×	168 0.5×	159 0.6×	30	1.6k
A.M.J. Chorus Netherlands	19	472 0.9×	261 0.6×	97 0.3×	433 1.4×	68 0.2×	47	1.9k
Rob Riemsma United Kingdom	22	110 0.2×	177 0.4×	194 0.6×	287 0.9×	155 0.5×	51	1.8k
Denise Globe United States	37	154 0.3×	329 0.7×	349 1.1×	855 2.8×	173 0.6×	106	3.6k

Countries citing papers authored by Ming‐Ann Hsu

Since Specialization

Citations

This map shows the geographic impact of Ming‐Ann Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Ann Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Ann Hsu more than expected).

Fields of papers citing papers by Ming‐Ann Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Ann Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Ann Hsu. The network helps show where Ming‐Ann Hsu may publish in the future.

Co-authorship network of co-authors of Ming‐Ann Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Ann Hsu. A scholar is included among the top collaborators of Ming‐Ann Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Ann Hsu. Ming‐Ann Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nash, Peter, Laura C. Coates, Dona Fleishaker, et al.. (2021). Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study. The Lancet Rheumatology. 3(4). e270–e283. 27 indexed citations

Coates, Laura C., Andrew G. Bushmakin, Oliver FitzGerald, et al.. (2021). Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib. Arthritis Research & Therapy. 23(1). 94–94. 9 indexed citations

Nash, Peter, Philip J. Mease, Dona Fleishaker, et al.. (2020). Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance. The Lancet Rheumatology. 3(1). e28–e39. 15 indexed citations

Lebwohl, Mark, Andrew G. Bushmakin, Eric L. Simpson, et al.. (2020). Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD. Dermatology and Therapy. 11(1). 221–233. 12 indexed citations

Nash, Peter, Laura C. Coates, Alan Kivitz, et al.. (2020). Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study. Rheumatology and Therapy. 7(3). 553–580. 48 indexed citations

Cella, David, Hilary Wilson, Dennis A. Revicki, et al.. (2019). Content validity and psychometric evaluation of Functional Assessment of Chronic Illness Therapy-Fatigue in patients with psoriatic arthritis. Journal of Patient-Reported Outcomes. 3(1). 30–30. 35 indexed citations

Helliwell, Philip, Laura C. Coates, Oliver FitzGerald, et al.. (2017). Tofacitinib Improves Composite Endpoint Measures of Disease in Patients with Psoriatic Arthritis. Oxford University Research Archive (ORA) (University of Oxford). 69. 900–901. 3 indexed citations

Lang, Kathleen, Ivy M. Alexander, James A. Simon, et al.. (2015). The Impact of Multimorbidity on Quality of Life Among Midlife Women: Findings from a U.S. Nationally Representative Survey. Journal of Women s Health. 24(5). 374–383. 24 indexed citations

Lam, Raymond W., Jean Endicott, Ming‐Ann Hsu, et al.. (2014). Predictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxine. International Clinical Psychopharmacology. 29(5). 239–251. 23 indexed citations

10.

Endicott, Jean, Raymond W. Lam, Ming‐Ann Hsu, et al.. (2014). Improvements in quality of life with desvenlafaxine 50mg/d vs placebo in employed adults with major depressive disorder. Journal of Affective Disorders. 166. 307–314. 13 indexed citations

11.

Trask, Peter C., Ming‐Ann Hsu, & Richard P. McQuellon. (2009). Other Paradigms: Health-Related Quality of Life as a Measure in Cancer Treatment. The Cancer Journal. 15(5). 435–440. 56 indexed citations

12.

Johnson, F. Reed, Brett Hauber, David Osoba, et al.. (2006). Are Chemotherapy Patients’ HRQoL Importance Weights Consistent with Linear Scoring Rules? A Stated-choice Approach. Quality of Life Research. 15(2). 285–298. 40 indexed citations

13.

Osoba, David, Ming‐Ann Hsu, Catherine Copley‐Merriman, et al.. (2006). Stated Preferences of Patients with Cancer for Health-related Quality-of-life (HRQOL) Domains During Treatment. Quality of Life Research. 15(2). 273–283. 58 indexed citations

14.

Lang, Kathleen, Joseph Menzin, Craig C. Earle, Jerilynn Jacobson, & Ming‐Ann Hsu. (2004). The Economic Cost of Squamous Cell Cancer of the Head and Neck. Archives of Otolaryngology - Head and Neck Surgery. 130(11). 1269–1269. 71 indexed citations

15.

Wood, Stacey, et al.. (2000). The Use of the Neuropsychiatric Inventory in Nursing Home Residents: Characterization and Measurement. American Journal of Geriatric Psychiatry. 8(1). 75–83. 378 indexed citations

16.

Leon, Joel, Peter J. Neumann, Richard C. Hermann, et al.. (2000). Health-related quality-of-life and service utilization in Alzheimer's disease: A cross-sectional study. 15(2). 94–108. 25 indexed citations

17.

Neumann, Peter J., Karen M. Kuntz, Joel Leon, et al.. (1999). Health Utilities in Alzheimer's Disease. Medical Care. 37(1). 27–32. 140 indexed citations

18.

Sneeuw, K.C.A., Neil K. Aaronson, David Osoba, et al.. (1997). The Use of Significant Others as Proxy Raters of the Quality of Life of Patients with Brain Cancer. Medical Care. 35(5). 490–506. 167 indexed citations

19.

Bayliss, Martha, Barbara Gandek, Kathleen M. Bungay, et al.. (1997). A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Quality of Life Research. 7(1). 39–55. 154 indexed citations

20.

Mulvihill, Michael, et al.. (1992). Tuberculosis surveillance in a long-term care facility. Archives of Gerontology and Geriatrics. 15(1). 29–34. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact